Innovation &
TEchnology Transfer
Spin-offs and Company Establishments
RCPE GmbH acts as a catalyst for innovation and technology transfer. We actively support the creation of spin-offs that transfer our scientific and engineering expertise into practical solutions for industry. These companies build on RCPE’s research, infrastructure, and networks to develop specialized products and services along the pharmaceutical and biopharmaceutical value chain.
Our spin-offs operate independently, but remain closely connected to RCPE through joint projects, shared know-how, and a common focus on innovation in pharmaceutical development and manufacturing. This page highlights selected spin-offs, licensees, and company establishments that were initiated or facilitated through collaboration with RCPE.
Our spin-offs
From Science to Business
Graz, Austria
SimVantage GmbH
Reactor simulations for optimization,
scale-up and troubleshooting
Founded
2021
Founder
Christian Witz, Philipp Eibl
Team size
6
SimVantage provides physics‑based bioreactor simulation to enable safer and faster scale‑up from laboratory to production scale. Its cloud‑based platform applies first‑principle Computational Fluid Dynamics (CFD) to make mixing, mass and heat transfer, and gas–liquid interactions in fermentation processes transparent and comparable across scales.
Used alongside experimental work, the resulting structured, traceable reports support Quality‑by‑Design‑driven process development, scale‑up and technology transfer in regulated environments. This helps biotech companies, CDMOs and pharmaceutical manufacturers reduce experimental effort, identify scale‑up risks early and strengthen process robustness.
Graz, Austria
MeltPrep GmbH
Tools for hot‑melt extrusion and formulation screening
Founded
2016
Founder
Daniel Treffer
Team size
20
MeltPrep develops innovative tools for rapid, lossless milligram-to-gram scale preparation of thermoplastic samples, enabling efficient screening of pharmaceutical formulations such as amorphous solid dispersions, hot-melt extruded dosage forms, implants, and 3D-printed medicines.
Their Vacuum Compression Molding (VCM) technology produces homogeneous, air-free prototypes while reducing time, cost, and complexity compared with conventional HME pilots, complemented by fast thermal analysis using the MeltPrep Slider.
Überherrn, Germany
PHOENIX-OITB gGmbH
Nano‑pharmaceutical Open Innovation Test Bed services
Founded
2023
CEO
Nazende Günday-Türeli
Team size
2
PHOENIX‑OITB is a non‑profit Open Innovation Test Bed offering a Single Entry Point to a European network of facilities, technologies and experts for nano‑pharmaceutical development. Its integrated service portfolio spans physico‑chemical characterization, in vitro and in vivo testing, scale‑up, GMP or GMP‑like manufacturing, and innovation support including regulatory and business guidance.
PHOENIX‑OITB supports SMEs, start‑ups and research groups in efficiently advancing nano‑pharmaceuticals from lab bench to clinical trials.
Graz, Austria
PRSG Pharmaceutical and Regulatory Services GmbH
Regulatory Affairs, Pharmacovigilance and Quality Management consulting
Founded
2012
Founder
Lydia Morawetz
Team size
7
PRSG is a consulting company specializing in Regulatory Affairs, Pharmacovigilance and Quality Management for the pharmaceutical, biotechnology and medical device industries. The company provides end‑to‑end regulatory support across the entire product lifecycle – from early development and marketing authorization to life‑cycle management and post‑marketing compliance at both European and national level.
PRSG helps clients efficiently navigate complex regulatory requirements for medicinal products, medical devices, food supplements, foods for special medical purposes (FSMPs) and cosmetics, while maintaining a strong focus on compliance and patient safety.
Villach, Austria
Roombiotic GmbH
Biological germ control and decontamination
Founded
2012
Founder
Stefan Liebminger
Team size
1
Roombiotic develops sustainable biological solutions for germ control based on volatile antimicrobial substances produced by beneficial microorganisms. The patented technology uses airborne active compounds to penetrate hard‑to‑reach areas and microstructures without solvents or residues, enabling gentle yet highly effective reduction of a broad spectrum of microorganisms.
This approach supports improved hygiene and product safety in hygiene‑critical environments such as food production, medicine, pharma and life sciences.
Graz, Austria
SES-Tec GmbH
Multi‑physics simulation and engineering consulting for pharmaceutical
Founded
2013
Founders
Dalibor Jajcevic, Wolfgang Lang
Team size
5
SES-Tec (Scientific & Engineering Simulation – Technology) is an engineering company specializing in multi-physics simulation, with a strong focus on pharmaceutical drug manufacturing processes. The company develops and applies advanced numerical methods in fluid dynamics, thermodynamics, structural mechanics, and process engineering to support complex industrial challenges.
SES-Tec supports its clients throughout the entire project lifecycle – from initial problem definition and model development to the integration of simulation results into real-world processes and products. Its services include the development of tailored simulation tools, engineering consulting, and project execution for the pharmaceutical and chemical industries, as well as specialized training in modern simulation methodologies.
facilitated by RCPE GmbH
Company Establishments
Graz, Austria
Phyllon GmbH
Real-time monitoring of pharmaceutical film coating
Founded
2016
Founder
Andrea Raffa, Gianpiero Raffa
Team size
5
Phyllon develops and supplies OSeeT, a process analytical technology based on Optical Coherence Tomography (OCT) that measures film‑coating thickness and structure on tablets, pellets, foils and films in real time. The system provides fast, non‑destructive cross‑sectional images that reveal mean coating thickness, variability between and within particles, and surface roughness.
OSeeT can also help to determine quality attributes of surface and structure of uncoated tablets. OSeeT helps pharmaceutical manufacturers monitor coating processes, detect malfunctions or poor set‑ups in coaters, and secure consistent product quality while reducing development and maintenance effort.
Graz, Austria
Artin Bioscience Europe GmbH
Disease‑modifying therapies for respiratory and immunological indications
Founded
2023
Founders
Norbert Voelkel, Charles Magolske
Team size
8
Artin Bioscience Inc. is a US biotech company developing disease‑modifying inhaled therapies for chronic obstructive pulmonary disease (COPD) and other severe respiratory and inflammatory conditions. Its platform aims to intervene in the underlying mechanisms of disease progression rather than only treating symptoms.
Artin Bioscience Europe GmbH in Graz serves as the European subsidiary, driving clinical development and future market access activities for COPD and related indications across Europe in cooperation with RCPE and other regional partners from the Austrian life‑science ecosystem.